ADC Therapeutics SA Share Price Today: Live Updates & Key Insights
ADC Therapeutics SA share price today is $1.165, up -5.74%. The stock opened at $1.25 against the previous close of $1.22, with an intraday high of $1.25 and low of $1.15.
ADC Therapeutics SA Share Price Chart
ADC Therapeutics SA
ADC Therapeutics SA Share Price Performance
ADC Therapeutics SA Institutional Holdings
ADC Therapeutics SA Market Status
ADC Therapeutics SA Fundamentals
Market Cap 155.17 M
PB Ratio 3.4239
PE Ratio 0.0
Enterprise Value 43.38 M
Total Assets 323.15 M
Volume 725745
ADC Therapeutics SA Company Financials
About ADC Therapeutics SA & investment objective
Company Information ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs). In addition, it is investigating a CD-22 targeted compound' and ADCT-602 that is in a Phase 1/2 IIT in refractory B-cell acute lymphoblastic leukemia. Further, the company's pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, NaPi2b, and ASCT2. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.
Organisation Drug Manufacturers - Specialty & Generic
Employees 188
Industry Drug Manufacturers - Specialty & Generic
CEO Dr. Ameet Mallik M.B.A., M.S.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ADC Therapeutics SA FAQs
What is the share price of ADC Therapeutics SA today?
The current share price of ADC Therapeutics SA is $1.165.
Can I buy ADC Therapeutics SA shares in India?
Yes, Indian investors can buy ADC Therapeutics SA shares by opening an international trading and demat account with Motilal Oswal.
How to buy ADC Therapeutics SA shares in India?
You can easily invest in ADC Therapeutics SA shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ADC Therapeutics SA shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ADC Therapeutics SA.
Can I buy fractional shares of ADC Therapeutics SA?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ADC Therapeutics SA?
ADC Therapeutics SA has a market cap of $155.17 M.
In which sector does ADC Therapeutics SA belong?
ADC Therapeutics SA operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in ADC Therapeutics SA stocks?
To invest, you typically need:
What is the PE and PB ratio of ADC Therapeutics SA?
The PE ratio of ADC Therapeutics SA is N/A and the PB ratio is 3.42.